Design, synthesis and docking study of novel tetracyclic oxindole derivatives as α-glucosidase inhibitors. 2015

Kailin Han, and Yashan Li, and Yazhou Zhang, and Yuou Teng, and Ying Ma, and Meiyan Wang, and Runling Wang, and Weiren Xu, and Qingwei Yao, and Yongmin Zhang, and Haijuan Qin, and Hua Sun, and Peng Yu
Key Laboratory of Industrial Fermentation Microbiology (Tianjin University of Science and Technology), Ministry of Education, Tianjin 300457, China; Tianjin Key Laboratory of Industry Microbiology, College of Biotechnology, Tianjin University of Science and Technology, Tianjin 300457, China; Sino-French Joint Lab of Food Nutrition/Safety and Medicinal Chemistry, Tianjin University of Science and Technology, Tianjin 300457, China.

A series of novel tetracyclic oxindole derivatives were synthesized via tandem Suzuki coupling-Michael addition reaction catalyzed by palladium. Twenty derivatives were designed and synthesized in 6-8 steps in 8-20% overall yields. Their structures were confirmed by (1)H, (13)C NMR and LC/MS. These compounds were evaluated for α-glucosidase inhibitory activity in vitro. Compounds 7c, 7d, 7e, 7g, 7h, and 7i exhibited IC50 values of 32.3, 12.1, 15.7, 29.0, 16.0, and 4.8 μM, respectively, with potency all higher than that of the control standard acarbose (IC50=115.8 μM). Molecular docking studies revealed the existence of potential hydrogen bonding and hydrophobic interaction between the enzyme and the active compound 7i.

UI MeSH Term Description Entries
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000520 alpha-Glucosidases Enzymes that catalyze the exohydrolysis of 1,4-alpha-glucosidic linkages with release of alpha-glucose. Deficiency of alpha-1,4-glucosidase may cause GLYCOGEN STORAGE DISEASE TYPE II. Acid Maltase,Lysosomal alpha-Glucosidase,Maltase,Maltases,Maltase-Glucoamylase,Neutral Maltase,Neutral alpha-Glucosidase,alpha-Glucosidase,Lysosomal alpha Glucosidase,Maltase Glucoamylase,Neutral alpha Glucosidase,alpha Glucosidase,alpha Glucosidases,alpha-Glucosidase, Lysosomal,alpha-Glucosidase, Neutral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking
D026121 Indole Alkaloids Group of alkaloids containing a benzylpyrrole group (derived from TRYPTOPHAN). Indole Alkaloid,Alkaloid, Indole,Alkaloids, Indole
D065089 Glycoside Hydrolase Inhibitors Compounds that inhibit or block the activity of GLYCOSIDE HYDROLASES such as ALPHA-AMYLASES and ALPHA-GLUCOSIDASES. alpha-Glucosidase Inhibitor,alpha-Glucosidase Inhibitors,Intestinal alpha-Amylase Inhibitors,Pancreatic alpha-Amylase Inhibitors,alpha-Amylase Inhibitors, Pancreatic,Hydrolase Inhibitors, Glycoside,Inhibitor, alpha-Glucosidase,Inhibitors, Glycoside Hydrolase,Inhibitors, Intestinal alpha-Amylase,Inhibitors, Pancreatic alpha-Amylase,Inhibitors, alpha-Glucosidase,Intestinal alpha Amylase Inhibitors,Pancreatic alpha Amylase Inhibitors,alpha Amylase Inhibitors, Pancreatic,alpha Glucosidase Inhibitor,alpha Glucosidase Inhibitors,alpha-Amylase Inhibitors, Intestinal

Related Publications

Kailin Han, and Yashan Li, and Yazhou Zhang, and Yuou Teng, and Ying Ma, and Meiyan Wang, and Runling Wang, and Weiren Xu, and Qingwei Yao, and Yongmin Zhang, and Haijuan Qin, and Hua Sun, and Peng Yu
October 2018, Computational biology and chemistry,
Kailin Han, and Yashan Li, and Yazhou Zhang, and Yuou Teng, and Ying Ma, and Meiyan Wang, and Runling Wang, and Weiren Xu, and Qingwei Yao, and Yongmin Zhang, and Haijuan Qin, and Hua Sun, and Peng Yu
July 2014, Bioorganic & medicinal chemistry,
Kailin Han, and Yashan Li, and Yazhou Zhang, and Yuou Teng, and Ying Ma, and Meiyan Wang, and Runling Wang, and Weiren Xu, and Qingwei Yao, and Yongmin Zhang, and Haijuan Qin, and Hua Sun, and Peng Yu
December 2023, Bioorganic chemistry,
Kailin Han, and Yashan Li, and Yazhou Zhang, and Yuou Teng, and Ying Ma, and Meiyan Wang, and Runling Wang, and Weiren Xu, and Qingwei Yao, and Yongmin Zhang, and Haijuan Qin, and Hua Sun, and Peng Yu
November 2016, Bioorganic & medicinal chemistry,
Kailin Han, and Yashan Li, and Yazhou Zhang, and Yuou Teng, and Ying Ma, and Meiyan Wang, and Runling Wang, and Weiren Xu, and Qingwei Yao, and Yongmin Zhang, and Haijuan Qin, and Hua Sun, and Peng Yu
April 2016, Bioorganic chemistry,
Kailin Han, and Yashan Li, and Yazhou Zhang, and Yuou Teng, and Ying Ma, and Meiyan Wang, and Runling Wang, and Weiren Xu, and Qingwei Yao, and Yongmin Zhang, and Haijuan Qin, and Hua Sun, and Peng Yu
January 2022, Frontiers in chemistry,
Kailin Han, and Yashan Li, and Yazhou Zhang, and Yuou Teng, and Ying Ma, and Meiyan Wang, and Runling Wang, and Weiren Xu, and Qingwei Yao, and Yongmin Zhang, and Haijuan Qin, and Hua Sun, and Peng Yu
April 2017, Molecules (Basel, Switzerland),
Kailin Han, and Yashan Li, and Yazhou Zhang, and Yuou Teng, and Ying Ma, and Meiyan Wang, and Runling Wang, and Weiren Xu, and Qingwei Yao, and Yongmin Zhang, and Haijuan Qin, and Hua Sun, and Peng Yu
February 2014, Bioorganic & medicinal chemistry,
Kailin Han, and Yashan Li, and Yazhou Zhang, and Yuou Teng, and Ying Ma, and Meiyan Wang, and Runling Wang, and Weiren Xu, and Qingwei Yao, and Yongmin Zhang, and Haijuan Qin, and Hua Sun, and Peng Yu
October 2023, Bioorganic chemistry,
Kailin Han, and Yashan Li, and Yazhou Zhang, and Yuou Teng, and Ying Ma, and Meiyan Wang, and Runling Wang, and Weiren Xu, and Qingwei Yao, and Yongmin Zhang, and Haijuan Qin, and Hua Sun, and Peng Yu
March 2017, Chemical biology & drug design,
Copied contents to your clipboard!